Shuntaro Ikawa

5.5k citations

70 papers · 4.8k indexed · 2 hit papers · h-index 30

Molecular Biology top 2%
Oncology top 1%
Cancer Research top 2%
Biotechnology top 0.5%
Radiology, Nuclear Medicine and Imaging top 2%

Co-authors: Tadashi Yamamoto Kentaro Semba Kumao Toyoshima Tetsu Akiyama Nobuo Nomura Toshiyuki Saito Nobuyuki Miyajima Yoji Ikawa
Topics: Cancer-related Molecular Pathways (23 papers)Cancer Research and Treatments (14 papers)RNA modifications and cancer (12 papers)
Cited by: Oncology Biotechnology Cancer Research
Journals: Nature Nucleic Acids Research Journal of Biological Chemistry
Partner nations: Japan United States Australia

In The Last Decade

Shuntaro Ikawa

69 papers receiving 4.6k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Similarity of protein encoded by the human c-erb-B-2 gene to epidermal growth factor receptor

1986 1.1k citations Shuntaro Ikawa, Kentaro Semba et al. profile →
A common polymorphism acts as an intragenic modifier of mutant p53 behaviour

2000 442 citations Shuntaro Ikawa et al. profile →

Peers

Countries citing papers authored by Shuntaro Ikawa

Since Specialization

Citations

This map shows the geographic impact of Shuntaro Ikawa's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Shuntaro Ikawa with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Shuntaro Ikawa more than expected).

Fields of papers citing papers by Shuntaro Ikawa

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Shuntaro Ikawa. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Shuntaro Ikawa. The network helps show where Shuntaro Ikawa may publish in the future.

Co-authorship network of co-authors of Shuntaro Ikawa

This figure shows the co-authorship network connecting the top 25 collaborators of Shuntaro Ikawa. A scholar is included among the top collaborators of Shuntaro Ikawa based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Shuntaro Ikawa. Shuntaro Ikawa is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Intracellular S1P Levels Dictate Fate of Different Regions of the Hippocampus following Transient Global Cerebral Ischemia 2018 ·Neuroscience ·Sherif Rashad,Kuniyasu Niizuma,Daisuke Saigusa,Xiaobo Han,Mika Sato‐Maeda,Ritsumi Saito,Akira Uruno,Miki Fujimura,Shuntaro Ikawa,Masayuki Yamamoto,Teiji Tominaga	15
2	Early BBB breakdown and subacute inflammasome activation and pyroptosis as a result of cerebral venous thrombosis 2018 ·Brain Research ·Sherif Rashad,Kuniyasu Niizuma,Mika Sato‐Maeda,Miki Fujimura,(unknown),Hidenori Endo,Shuntaro Ikawa,Teiji Tominaga	55
3	Transient Global Cerebral Ischemia Induces RNF213 , a Moyamoya Disease Susceptibility Gene, in Vulnerable Neurons of the Rat Hippocampus CA1 Subregion and Ischemic Cortex 2017 ·Journal of Stroke and Cerebrovascular Diseases ·Mika Sato‐Maeda,Miki Fujimura,Sherif Rashad,Yuiko Morita‐Fujimura,Kuniyasu Niizuma,Hiroyuki Sakata,Shuntaro Ikawa,Teiji Tominaga	12
4	ΔNp63α induces quiescence and downregulates the BRCA1 pathway in estrogen receptor‐positive luminal breast cancer cell line MCF7 but not in other breast cancer cell lines 2015 ·Molecular Oncology ·Ruhul Amin,Yuiko Morita‐Fujimura,Hiroshi Tawarayama,Kentaro Semba,Natsuko Chiba,Manabu Fukumoto,Shuntaro Ikawa	19
5	Notch down-regulation in regenerated epidermis contributes to enhanced expression of interleukin-36α and suppression of keratinocyte differentiation during wound healing 2015 ·Journal of Dermatological Science ·(unknown),Eisaku Ogawa,Rumiko Saito,(unknown),Shuntaro Ikawa,Hisashi Uhara,Ryuhei Okuyama	15
6	c-ABL tyrosine kinase modulates p53-dependent p21 induction and ensuing cell fate decision in response to DNA damage 2013 ·Cellular Signalling ·S. M. Nashir Udden,Yuiko Morita‐Fujimura,Masanobu Satake,Shuntaro Ikawa	16
7	Epidermal FABP (FABP5) Regulates Keratinocyte Differentiation by 13(S)-HODE-Mediated Activation of the NF-κB Signaling Pathway 2010 ·Journal of Investigative Dermatology ·Eisaku Ogawa,Yuji Owada,Shuntaro Ikawa,Yasuhiro Adachi,(unknown),(unknown),Kaori Suzuki,Takanori Hishinuma,Hiroshi Kawashima,Hisatake Kondo,Masahiko Muto,Setsuya Aiba,Ryuhei Okuyama	77
8	p63/p51-induced Onset of Keratinocyte Differentiation via the c-Jun N-terminal Kinase Pathway Is Counteracted by Keratinocyte Growth Factor 2008 ·Journal of Biological Chemistry ·Eisaku Ogawa,Ryuhei Okuyama,(unknown),(unknown),Masuo Obinata,Hachiro Tagami,Shuntaro Ikawa,Setsuya Aiba	32
9	p51/p63 inhibits ultraviolet B-induced apoptosis via Akt activation 2007 ·Oncogene ·Eisaku Ogawa,Ryuhei Okuyama,Shuntaro Ikawa,(unknown),(unknown),(unknown),Masato Yabuki,Hachiro Tagami,Masuo Obinata,Setsuya Aiba	19
10	p51/p63, a novel p53 homologue, potentiates p53 activity and is a human cancer gene therapy candidate 2006 ·The Journal of Gene Medicine ·Reiko Kunisaki,Shuntaro Ikawa,Toyoki Maeda,Yukoh Nakazaki,Ryo Kurita,(unknown),(unknown),(unknown),Yasushi Soda,Tsuyoshi Tanabe,Taeko Dohi,Rie Kato,Yoji Ikawa,Shigetaka Asano,Kenzaburo Tani	18
11	Structure and the evolutionary implication of the triplicated complement factor B genes of a urochordate ascidian, Ciona intestinalis 2005 ·Immunogenetics ·Fumiko Yoshizaki,Shuntaro Ikawa,Masanobu Satake,Nori Satoh,Masaru Nonaka	33
12	Cloning and characterization of Xenopus laevis drg2, a member of the developmentally regulated GTP-binding protein subfamily 2003 ·Gene ·Kosuke Ishikawa,Sakura Azuma,Shuntaro Ikawa,Yasuyuki Morishita,Jin Gohda,Taishin Akiyama,Kentaro Semba,Jun‐ichiro Inoue	19
13	p51A (TAp63γ), a p53 homolog, accumulates in response to DNA damage for cell regulation 2000 ·Oncogene ·Iyoko Katoh,Ken‐ichi Aisaki,Shun‐ichi Kurata,Shuntaro Ikawa,Yoji Ikawa	73
14	Functional impairment of p73 and p51, the p53-related proteins, by the human T-cell leukemia virus type 1 Tax oncoprotein 2000 ·Oncogene ·Atsushi Kaida,Yasuo Ariumi,Yoshihide Ueda,(unknown),Makoto Hijikata,Shuntaro Ikawa,Kunitada Shimotohno	32
15	Mutational analysis of p51A/TAp63γ, a p53 homolog, in non-small cell lung cancer and breast cancer 1999 ·Oncogene ·Masao Sunahara,Tomotane Shishikura,Masato Takahashi,Satoru Todo,Naoyoshi Yamamoto,Hideki Kimura,Shunsuke Kato,Chikashi Ishioka,Shuntaro Ikawa,Yoji Ikawa,Akira Nakagawara	47
16	The Ah Receptor Is Not Involved in 2,3,7,8-Tetrachlorodibenzo-p-dioxin-mediated Apoptosis in Human Leukemic T Cell Lines 1998 ·Journal of Biological Chemistry ·Anwar Hossain,Shigeru Tsuchiya,Masayoshi Minegishi,Motonobu Osada,Shuntaro Ikawa,(unknown),Mitsuji Kaji,Tasuke Konno,(unknown),Hideaki Kikuchi	65
17	Identification of Cellular Protein That Can Interact Specifically with the Basic Helix-Loop-Helix Domain of the Aromatic Hydrocarbon Receptor 1995 ·Biochemical and Biophysical Research Communications ·Anwar Hossain,Haruhisa Kikuchi,Shuntaro Ikawa,Ikuko Sagami,Mayumi Watanabe	3
18	Aberrant CYP1A1 Induction: Discrepancy of CYP1A1 mRNA and Aryl Hydrocarbon Hydroxylase Activity in Mutant Cells of Mouse Hepatoma Line, Hepa‐1 1994 ·Japanese Journal of Cancer Research ·Hideaki Kikuchi,Masahiro Usuda,Ikuko Sagami,Shuntaro Ikawa,(unknown)	2
19	Restriction fragment length polymorphism of the human CYP 2E1 (cytochrome P450IIE1) gene and susceptibility to lung cancer 1994 ·Pharmacogenetics ·Fumiyuki Uematsu,Shuntaro Ikawa,Hideaki Kikuchi,Ikuko Sagami,Ryunosuke Kanamaru,Tatsuya Abé,Ken Satoh,Masakichi Motomiya,(unknown)	91
20	Characterization of Hamster CYP1A1 Gene: Inducible Expression and Negative Regulation1 1994 ·The Journal of Biochemistry ·Ikuko Sagami,Hideaki Kikuchi,Shuntaro Ikawa,(unknown)	10

About Shuntaro Ikawa

Shuntaro Ikawa is a scholar working on Biotechnology, Oncology and Cancer Research, having authored 70 papers that have together received 4.8k indexed citations. Recurring topics across this work include Cancer-related Molecular Pathways (23 papers), Cancer Research and Treatments (14 papers) and RNA modifications and cancer (12 papers). The work is most often cited by research in Oncology (2.4k citations), Biotechnology (617 citations) and Cancer Research (726 citations). Shuntaro Ikawa has collaborated with scholars based in Japan, United States and Australia. Frequent co-authors include Tadashi Yamamoto, Kentaro Semba, Kumao Toyoshima, Tetsu Akiyama, Nobuo Nomura, Toshiyuki Saito, Nobuyuki Miyajima, Yoji Ikawa, Masuo Obinata and Akira Nakagawara. Their work appears in journals such as Nature, Nucleic Acids Research and Journal of Biological Chemistry.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact